OGIMVA (U.S. Trademark Serial Number 79147176) is a United States trademark of ALFASIGMA S.P.A.. The goods and services include: Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in haematology, in oncology in transplantation, in ophthalmology, for use in the gastroenterological areas and the prevention and treatment of ocular disorders or diseases, anti-infectives, pharmaceutical preparations treating bacterial-based disease, antivirals, antibiotics, antifungals, vaccines, diagnostic preparations for medical use The wording OGIMVA has no meaning in a foreign language. . The correspondent is BUGNION S.P.A. of Via di Corticella, 87.
This trademark was filed on February 27, 2014 as United States Trademark Application Serial Number 79147176. The trademark application was registered on September 30, 2014 as U.S. Trademark Registration 4611938.
Trademark PTO Status History
July 04, 2022 – TOTAL INVALIDATION PROCESSED BY THE IB
April 22, 2022 – TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
April 22, 2022 – INVALIDATION PROCESSED
December 16, 2021 – TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
April 16, 2021 – CANCELLED SECTION 71
August 24, 2018 – CHANGE OF NAME/ADDRESS REC’D FROM IB
February 01, 2018 – CHANGE OF OWNER RECEIVED FROM IB
February 06, 2015 – NOTIFICATION PROCESSED BY IB
View full trademark status information at USPTO
Ownership History
ALFASIGMA S.P.A.
SIGMA-TAU; INDUSTRIE FARMACEUTICHE RIUNITE S.p.A.
SIGMA-TAU; INDUSTRIE FARMACEUTICHE RIUNITE S.p.A.
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.